Article Details

Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into ...

Retrieved on: 2022-09-17 21:17:36

Tags for this article:

Click the tags to see associated articles and topics

Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into .... View article details on hiswai:

Excerpt

... biological understanding of T cell function and receptor signaling to create a world in which everyone's immune system can defeat cancer.

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up